AscendBio - Pioneering Cell Therapy Cures

AscendBio’s mission is to transform the lives of patients with life-threatening metabolic and respiratory diseases.

We have developed an optimized synthetic biology approach to generate new classes of highly functional curative cell therapy medicines by the Integrated Programming of stem cells.

Our unique Integrated Programming platform harnesses directed differentiation, forward programming and tissue environment engineering to develop novel cell types configured for therapeutic production.

The technology platform builds on the pioneering work of founder and CSO, Ludovic Vallier, Einstein Professor for Stem Cells in Regenerative Therapies at the Berlin Institute of Health at Charité (BIH).

We are also leveraging our total synthetic biology platform to construct tools which can benefit the stem cell industrial ecosystem and expand the global regenerative medicine advanced therapy sector.

Babraham Research Campus
Cambridge, CB22 3AT, United Kingdom